NO20032304D0 - Anvendelse av selektive dopamin D4-reseptoragonister for behandling av seksuell dysfunksjon - Google Patents

Anvendelse av selektive dopamin D4-reseptoragonister for behandling av seksuell dysfunksjon

Info

Publication number
NO20032304D0
NO20032304D0 NO20032304A NO20032304A NO20032304D0 NO 20032304 D0 NO20032304 D0 NO 20032304D0 NO 20032304 A NO20032304 A NO 20032304A NO 20032304 A NO20032304 A NO 20032304A NO 20032304 D0 NO20032304 D0 NO 20032304D0
Authority
NO
Norway
Prior art keywords
treatment
receptor agonists
sexual dysfunction
selective dopamine
dopamine
Prior art date
Application number
NO20032304A
Other languages
English (en)
Other versions
NO20032304L (no
Inventor
Jorge D Brioni
Gin C Hsieh
Diane L Donnelly-Roberts
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27109879&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20032304(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US09/985,974 external-priority patent/US20020103105A1/en
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of NO20032304D0 publication Critical patent/NO20032304D0/no
Publication of NO20032304L publication Critical patent/NO20032304L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20032304A 2000-11-22 2003-05-21 Anvendelse av selektive dopamin D4-reseptoragonister for behandling av seksuell dysfunksjon NO20032304L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US71831100A 2000-11-22 2000-11-22
US09/985,974 US20020103105A1 (en) 2000-11-22 2001-11-07 Use of selective dopamine D4 receptor agonists for treating sexual dysfunction
PCT/US2001/043139 WO2002041894A2 (en) 2000-11-22 2001-11-21 Selective dopamine d4 receptor agonists for treating sexual dysfunction

Publications (2)

Publication Number Publication Date
NO20032304D0 true NO20032304D0 (no) 2003-05-21
NO20032304L NO20032304L (no) 2003-07-15

Family

ID=27109879

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032304A NO20032304L (no) 2000-11-22 2003-05-21 Anvendelse av selektive dopamin D4-reseptoragonister for behandling av seksuell dysfunksjon

Country Status (25)

Country Link
EP (1) EP1345608B1 (no)
JP (1) JP2004534725A (no)
KR (1) KR20030051857A (no)
CN (1) CN1531434A (no)
AR (1) AR035600A1 (no)
AT (1) ATE358483T1 (no)
AU (2) AU2002226895B2 (no)
BG (1) BG107810A (no)
BR (1) BR0110450A (no)
CA (1) CA2429383A1 (no)
CZ (1) CZ20031458A3 (no)
DE (1) DE60127712T2 (no)
ES (1) ES2284727T3 (no)
HK (1) HK1059884A1 (no)
HU (1) HUP0402358A3 (no)
IL (1) IL155094A0 (no)
MX (1) MXPA03004547A (no)
NO (1) NO20032304L (no)
NZ (1) NZ525086A (no)
PE (1) PE20020557A1 (no)
PL (1) PL365890A1 (no)
SK (1) SK7242003A3 (no)
TW (1) TWI293254B (no)
UY (1) UY27031A1 (no)
WO (1) WO2002041894A2 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA78974C2 (en) 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
AU2003231801A1 (en) * 2002-05-23 2003-12-12 Abbott Laboratories Acetamides and benzamides that are useful in treating sexual dysfunction
US8227476B2 (en) 2005-08-03 2012-07-24 Sprout Pharmaceuticals, Inc. Use of flibanserin in the treatment of obesity
WO2007048803A1 (en) 2005-10-29 2007-05-03 Boehringer Ingelheim International Gmbh Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders
WO2008000760A1 (en) 2006-06-30 2008-01-03 Boehringer Ingelheim International Gmbh Flibanserin for the treatment of urinary incontinence and related diseases
BRPI0716439B8 (pt) 2006-08-14 2021-05-25 Boehringer Ingelheim Int sistemas de liberação farmacêutico compreendendo flibanserina, processo para preparação e uso dos mesmos
BRPI0716436B8 (pt) 2006-08-25 2021-05-25 Boehringer Ingelheim Int sistema de liberação controlada e método para fabricação do mesmo
UY31335A1 (es) 2007-09-12 2009-04-30 Tratamiento de sintomas vasomotores
US9353067B2 (en) * 2011-04-10 2016-05-31 Atir Holding S.A. Heterocyclic compounds and uses thereof in the treatment of sexual disorders
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996004250A1 (en) * 1994-08-05 1996-02-15 Pfizer Inc. Benzimidazole derivatives having dopaminergic activity
US5945117A (en) * 1998-01-30 1999-08-31 Pentech Pharmaceuticals, Inc. Treatment of female sexual dysfunction
EP0982030A3 (en) * 1998-08-17 2000-05-10 Pfizer Products Inc. 2,7-substituted octahydro-pyrrolo 1,2-a]pyrazine derivatives as 5ht 1a ligands
US6291471B1 (en) * 1998-12-17 2001-09-18 Abb Holdings, Inc. Use of apomorphine for the treatment of organic erectile dysfunction in males

Also Published As

Publication number Publication date
CZ20031458A3 (cs) 2004-02-18
NZ525086A (en) 2006-07-28
AR035600A1 (es) 2004-06-16
HUP0402358A2 (hu) 2005-03-29
EP1345608A2 (en) 2003-09-24
BG107810A (bg) 2004-02-27
PE20020557A1 (es) 2002-06-25
AU2002226895B2 (en) 2006-10-12
AU2689502A (en) 2002-06-03
IL155094A0 (en) 2003-10-31
CA2429383A1 (en) 2002-05-30
EP1345608B1 (en) 2007-04-04
HUP0402358A3 (en) 2009-08-28
DE60127712D1 (de) 2007-05-16
WO2002041894A2 (en) 2002-05-30
BR0110450A (pt) 2005-02-09
MXPA03004547A (es) 2004-03-26
HK1059884A1 (en) 2004-07-23
JP2004534725A (ja) 2004-11-18
SK7242003A3 (en) 2004-01-08
ATE358483T1 (de) 2007-04-15
NO20032304L (no) 2003-07-15
UY27031A1 (es) 2002-07-31
PL365890A1 (en) 2005-01-10
TWI293254B (en) 2008-02-11
KR20030051857A (ko) 2003-06-25
ES2284727T3 (es) 2007-11-16
DE60127712T2 (de) 2007-12-27
CN1531434A (zh) 2004-09-22
WO2002041894A3 (en) 2002-10-17

Similar Documents

Publication Publication Date Title
NO20032360L (no) EP4 reseptor selektive agonister for behandling av osteoporose
ATE250575T1 (de) Ep4 rezeptor selektive agonisten zur behandlung der osteoporose
NO20034122L (no) Sammensmeltede pyridinderivater for anvendelse som vanilloidreseptorantagonister for behandling av smerte
NO20030213D0 (no) Anvendelse av D2/D3 reseptor-agonister for behandling av fibromyalgi
NO20033508D0 (no) Medikament med hurtig virkningsbegynnelse for behandling av seksuell dysfunksjon
IS2494B (is) Notkun á morfólínóli til meðhöndlunar á kynferðislegri vanvirkni
DE60132799D1 (de) Peroxisom proliferator aktivierten rezeptor alpha agonisten
ZA200501308B (en) Agonism of the 5HT2a receptor for treatment of thermoregulatory dysfunction
DE60032905D1 (de) Selektive iglur5 rezeptorantagonisten zur behandlung der migräne
DK1117403T3 (da) MGLUR5-antagonister til behandling af smerte og angst
AR028579A1 (es) Metodo para el tratamiento de la sequedad vaginal, con agonistas del receptor de acetilcolina nicotinica
NO20032304D0 (no) Anvendelse av selektive dopamin D4-reseptoragonister for behandling av seksuell dysfunksjon
NO20052557L (no) Morfolinderivater for bruk som dopamin-agonister i behandling av blant annet seksuell dysfunksjon.
NO20042737L (no) Peroksisomproliferatoraktiverte receptoragonister
ATE366572T1 (de) 5-ht 1b/1d rezeptor agonisten zur behandlung von kopfschmerz der aus der verabreichung von endothelin rezeptor antagonisten resultiert
PL370842A1 (en) Selective dopamin d3 receptor agonists for the treatment of sexual dysfunction
IS8388A (is) Blandan af serótónín endurupptökuhindra og histamín 3 viðtaka mótlyfi, öflugum verka eða hlutaverka
NO20022142D0 (no) Anvendelse av dopamin-D3 reseptor agonister for behandling av saltavhengig hypertensjon
NO20033160D0 (no) Anordning for behandling av gravann
ES1050969Y (es) Dispositivo perfeccionado de arriostramiento de andamios tubulares.
MY155220A (en) Selective dopamine d4 receptor agonists for treating sexual dysfunction
ES1048488Y (es) Dispositivo mecanico para prolongar la ereccion del pene.
DOP2001000290A (es) Agonista selectivos del receptor ep4 en el tratamiento de la osteoporosis

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application